Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissue
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 25, 1997
Grant Date -
N/A
app pub date -
Mar 15, 1996
filing date -
May 22, 1993
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Pharmaceutical compositions comprising dihydrolipoic acid or physiologically acceptable salts thereof are disclosed for the treatment of eye diseases and intolerance reactions in the area between implants and endoprostheses, in particular ophthalmological implants and endoprostheses with living body tissue.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully